Reporting COVID-19 Vaccinations in the United States
Information on COVID-19 vaccination data reported in CDC’s COVID Data Tracker. 2019 Novel Coronavirus
Category: Local News
COVID Data Tracker Weekly Review
A review of the week’s key data from CDC’s COVID Data Tracker, narrative interpretations, and visualizations. 2019 Novel Coronavirus
Reporting COVID-19 Vaccination Demographic Data
CDC’s COVID Data Tracker provides COVID-19 vaccination data in the United States, including Demographic Characteristics of People Receiving COVID-19 Vaccinations in the United States. 2019 Novel Coronavirus
Variant Proportions in the U.S.
CDC uses data provided through its national SARS-CoV-2 genomic surveillance program to estimate the proportion of variants circulating in the United States. These data inform national and state public health actions. 2019 Novel Coronavirus
COVID-19 Vaccination
Learn the 10 things healthcare professionals need to know about where U.S. COVID-19 vaccination planning currently stands. 2019 Novel Coronavirus
Transmission of SARS-CoV-2 in K-12 schools
COVID-19 transmission in schools is associated with community transmission. Transmission spread within schools can be limited with strict implementation of layered mitigation strategies. 2019 Novel Coronavirus
Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting
Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting 2019 Novel Coronavirus
Overview of Testing for SARS-CoV-2 (COVID-19)
Overview of Testing for SARS-CoV-2 2019 Novel Coronavirus
Selected Adverse Events Reported after COVID-19 Vaccination
COVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history. CDC recommends you get a…
COVID-19 survey data added to All of Us platform
by Paul Govern In December 2020, the federal government’s massive precision medicine research initiative, All of Us (AoU), made available to qualified researchers initial results from its ongoing COVID-19 Participant Experience (COPE) Survey, as…